The scrutiny follows Wilson Medical Center’s brush with CMS this past summer, when its Medicare contract was risked after state regulators identified immediate jeopardy to patients’ health and safety stemming from three events in early 2022. The hospital submitted a corrective action plan to CMS June 28, and on Aug. 5, a hospital spokesperson told Becker’s the hospital was no longer at risk of losing its Medicare contract.
In a follow-up review of 294-bed Wilson Medical Center, inspectors still found “substantial noncompliance” with Medicare rules, which the hospital had until the end of September to fix, The N&O reports.
A spokesperson for the hospital told The N&O the Wilson Medical Center “continues to work with CMS as it reviews a few recent complaints,” which are related to potential EMTALA violations.
To receive Medicare funding, hospitals that offer emergency services must provide a medical screening examination when a request is made for examination or treatment for an emergency medical condition, regardless of the patient’s ability to pay.
“We have cooperated fully with the state surveyors and CMS with the EMTALA investigations,” hospital spokesperson Melanie Raynor told The N&O. “That information has been gathered, compiled by the state, and sent to CMS to review.”
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
